Human immunoglobulin

DRUG2 trials

Sponsors

Centre Hospitalier St Anne, Centenario Hospital Miguel Hidalgo

Conditions

Acute Respiratory Distress SyndromeCOVID-19COVID-19 Pneumonia

Phase 3

Polyvalent Immunoglobulin in COVID-19 Related ARds

CompletedNCT04350580

Centre Hospitalier St AnneAcute Respiratory Distress Syndrome, COVID-19

Start: 2020-04-11End: 2021-02-20Updated: 2021-08-19

Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia

CompletedNCT04381858

Centenario Hospital Miguel HidalgoCOVID-19 Pneumonia

Start: 2020-05-06End: 2020-11-26Updated: 2020-11-30

Related Papers

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.

2021-11-1144 citations

Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.

2021-02-282 citations